Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.541, 2007-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
XENDOS: orlistat can prevent diabetes in obese patients
Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. :
Access to resources
Recommend
Orlistat may reduce cyclosporin concentrations: concerns voiced
Inpharma, Vol. 1, Iss. 1234, 2000-01 ,pp. :
Drugs, Vol. 56, Iss. 2, 1998-08 ,pp. :
The Journal of Drug Evaluation, Vol. 2, Iss. 7, 2004-01 ,pp. :
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients
By Derosa Giuseppe Maffioli Pamela Salvadeo Sibilla AT Ferrari Ilaria Gravina Alessia Mereu Roberto D'Angelo Angela Fogari Elena Palumbo Ilaria Randazzo Sabrina Cicero Arrigo FG
Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. :